A key to controlling arthrosis
Up to the present, we could only hope to reduce the symptoms of arthrosis, or be satisfied with replacing the affected joint. A study involving a “new” molecule has changed things. In effect, strontium ranelate has slowed down the progression of disease in the patients’ knees. These results should accelerate the development of a new form of treatment.
The mysteries of the joint
In case of arthrosis in a joint (here, mainly the knee, the hip, the big toe or fingers), the damaged cartilage disappears little by little; the bone which it covers (the subchondral bone) then directly rubs against the bone or adjacent cartilage, with the risk of cracking and causing pain. It is believed that 10 % of the population is affected by this degenerative joint disease, and women are particularly affected.
(1) Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis ; rational and design of randomised, double-blind, placebo-controlled trial. Cyrus Cooper, Jean-Yves Reginster, Roland Chapurlat, Claus Christiansen, Harry Genant, Nicholas Bellamy, William Bensen, Federico Navarro, Janusz Badurski, Evgeny Nasonov, Xavier Chevalier, Philip N.Sambrook, in Current medcial Research&Opinion. Vol 28.N°2, 2012, 231-239.